FierceBiotech

After mulling its options for the…

news2026-04-28T10:37:00+00:00April 28th, 2026|FierceBiotech|

AbbVie has agreed to help finance…

news2026-04-28T10:04:00+00:00April 28th, 2026|FierceBiotech|

Incyte’s povorcitinib has scored…

news2026-04-28T09:19:00+00:00April 28th, 2026|FierceBiotech|

Erasca has backed up bullish…

news2026-04-28T08:57:00+00:00April 28th, 2026|FierceBiotech|

Eli Lilly’s latest attempt to…

news2026-04-28T08:21:00+00:00April 28th, 2026|FierceBiotech|

Novartis is “continuing to…

news2026-04-28T03:22:00+00:00April 28th, 2026|FierceBiotech|

While the result fell short of the…

news2026-04-28T02:49:00+00:00April 28th, 2026|FierceBiotech|

For Jake Becraft, Ph.D., the…

news2026-04-28T02:42:00+00:00April 28th, 2026|FierceBiotech|

After a disappointing phase 1…

news2026-04-27T17:47:00+00:00April 27th, 2026|FierceBiotech|

After launching in 2025 as a…

news2026-04-27T14:51:00+00:00April 27th, 2026|FierceBiotech|

Previous272829Next